Page last updated: 2024-09-04

xamoterol and h 89

xamoterol has been researched along with h 89 in 1 studies

Compound Research Comparison

Studies
(xamoterol)
Trials
(xamoterol)
Recent Studies (post-2010)
(xamoterol)
Studies
(h 89)
Trials
(h 89)
Recent Studies (post-2010) (h 89)
26980171,6190409

Protein Interaction Comparison

ProteinTaxonomyxamoterol (IC50)h 89 (IC50)
Rho-associated protein kinase 2Homo sapiens (human)1.9504
Ribosomal protein S6 kinase alpha-5Homo sapiens (human)0.12
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)0.073
cAMP-dependent protein kinase catalytic subunit alpha Mus musculus (house mouse)0.381
cAMP-dependent protein kinase catalytic subunit alphaHomo sapiens (human)0.6365
cAMP-dependent protein kinase catalytic subunit gammaHomo sapiens (human)0.6365
cAMP-dependent protein kinase catalytic subunit betaHomo sapiens (human)0.6365
Ribosomal protein S6 kinase beta-1Homo sapiens (human)0.08
RAC-alpha serine/threonine-protein kinaseHomo sapiens (human)1.9886
RAC-beta serine/threonine-protein kinaseHomo sapiens (human)0.5417
Rho-associated protein kinase 2Rattus norvegicus (Norway rat)0.27
RAC-gamma serine/threonine-protein kinaseHomo sapiens (human)0.3207

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoizey, G; Millart, H; Robinet, A1

Other Studies

1 other study(ies) available for xamoterol and h 89

ArticleYear
PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning.
    Cardiovascular research, 2005, Jun-01, Volume: 66, Issue:3

    Topics: Adrenergic beta-Agonists; Androstadienes; Animals; Blotting, Western; Chromones; Coronary Circulation; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Heart Rate; Ischemic Preconditioning, Myocardial; Isoquinolines; Male; Morpholines; Myocardial Reperfusion Injury; Myocardium; Oxidopamine; Perfusion; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase C; Rats; Rats, Wistar; Sulfonamides; Wortmannin; Xamoterol

2005